Skip to main content
Erschienen in: European Journal of Drug Metabolism and Pharmacokinetics 6/2016

01.12.2016 | Original Research Article

Presence of an H+/Quinidine Antiport System in Madin–Darby Canine Kidney Cells

verfasst von: Miki Fukao, Eri Kondo, Hiroki Nishino, Ryutaro Hattori, Asuka Horie, Yukiya Hashimoto

Erschienen in: European Journal of Drug Metabolism and Pharmacokinetics | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives

We have recently found an H+/quinidine antiport system in human kidney HEK 293 cells. The aim of the present study was to evaluate whether the H+/quinidine antiport system is expressed in Madin–Darby canine kidney (MDCK) cells.

Methods

We investigated the uptake and efflux of quinidine in MDCK cells.

Results

The uptake of 100 µM quinidine into MDCK cells was decreased by acidification of extracellular pH or alkalization of intracellular pH. In addition, the uptake of quinidine was highly temperature sensitive, but was extracellular Na+ and membrane potential independent. Furthermore, tetraethylammonium, a typical substrate of renal organic cation transporters, did not inhibit the uptake of quinidine in MDCK cells. On the other hand, lipophilic cationic drugs, such as clonidine, bisoprolol, diphenhydramine, pyrilamine, and imipramine, significantly decreased the uptake of quinidine in MDCK cells. The uptake of quinidine was saturable, and the Michaelis–Menten constant was estimated to be approximately 0.5 mM. In addition, the efflux of quinidine from MDCK cells was increased by the acidification of extracellular pH, suggesting that the transport system mediates not only the uptake, but also secretion of quinidine.

Conclusions

The present findings suggested that the renal new antiport system is involved in the bidirectional membrane transport of quinidine in MDCK cells.
Literatur
1.
Zurück zum Zitat Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24:1227–51.CrossRefPubMed Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24:1227–51.CrossRefPubMed
3.
Zurück zum Zitat Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells. Drug Metab Pharmacokinet. 2008;23:340–6.CrossRefPubMed Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells. Drug Metab Pharmacokinet. 2008;23:340–6.CrossRefPubMed
4.
Zurück zum Zitat Masago M, Takaai M, Sakata J, Horie A, Ito T, Ishida K, Taguchi M, Hashimoto Y. Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells. Biol Pharm Bull. 2010;33:1407–12.CrossRefPubMed Masago M, Takaai M, Sakata J, Horie A, Ito T, Ishida K, Taguchi M, Hashimoto Y. Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells. Biol Pharm Bull. 2010;33:1407–12.CrossRefPubMed
5.
Zurück zum Zitat Horie A, Ishida K, Shibata K, Taguchi M, Ozawa A, Hirono K, Ichida F, Hashimoto Y. Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption. Biopharm Drug Dispos. 2014;35:145–53.CrossRefPubMed Horie A, Ishida K, Shibata K, Taguchi M, Ozawa A, Hirono K, Ichida F, Hashimoto Y. Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption. Biopharm Drug Dispos. 2014;35:145–53.CrossRefPubMed
6.
Zurück zum Zitat Horie A, Ishida K, Watanabe Y, Shibata K, Hashimoto Y. Membrane transport mechanisms of choline in human intestinal epithelial LS180 cells. Biopharm Drug Dispos. 2014;35:532–42.CrossRefPubMed Horie A, Ishida K, Watanabe Y, Shibata K, Hashimoto Y. Membrane transport mechanisms of choline in human intestinal epithelial LS180 cells. Biopharm Drug Dispos. 2014;35:532–42.CrossRefPubMed
7.
Zurück zum Zitat Ishida K, Horie A, Nishimura M, Taguchi M, Fujii N, Nozawa T, Inoue H, Hashimoto Y. Variability of bioavailability and intestinal absorption characteristics of bisoprolol. Drug Metab Pharmacokinet. 2013;28:491–6.CrossRefPubMed Ishida K, Horie A, Nishimura M, Taguchi M, Fujii N, Nozawa T, Inoue H, Hashimoto Y. Variability of bioavailability and intestinal absorption characteristics of bisoprolol. Drug Metab Pharmacokinet. 2013;28:491–6.CrossRefPubMed
8.
Zurück zum Zitat Mizuuchi H, Katsura T, Saito H, Hashimoto Y, Inui KI. Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system. J Pharmacol Exp Ther. 1999;290:388–92.PubMed Mizuuchi H, Katsura T, Saito H, Hashimoto Y, Inui KI. Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system. J Pharmacol Exp Ther. 1999;290:388–92.PubMed
9.
Zurück zum Zitat Jans AW, Amsler K, Griewel B, Kinne RK. Regulation of intracellular pH in LLC-PK1 cells studied using 31P-NMR spectroscopy. Biochim Biophys Acta. 1987;927:203–12.CrossRefPubMed Jans AW, Amsler K, Griewel B, Kinne RK. Regulation of intracellular pH in LLC-PK1 cells studied using 31P-NMR spectroscopy. Biochim Biophys Acta. 1987;927:203–12.CrossRefPubMed
10.
Zurück zum Zitat Gerhardt RE, Knouss RF, Thyrum PT, Luchi RJ, Morris JJ Jr. Quinidine excretion in aciduria and alkaluria. Ann Intern Med. 1969;71:927–33.CrossRefPubMed Gerhardt RE, Knouss RF, Thyrum PT, Luchi RJ, Morris JJ Jr. Quinidine excretion in aciduria and alkaluria. Ann Intern Med. 1969;71:927–33.CrossRefPubMed
11.
Zurück zum Zitat Hertrampf R, Gundert-Remy U, Beckmann J, Hoppe U, Elsässer W, Stein H. Elimination of flecainide as a function of urinary flow rate and pH. Eur J Clin Pharmacol. 1991;41:61–3.CrossRefPubMed Hertrampf R, Gundert-Remy U, Beckmann J, Hoppe U, Elsässer W, Stein H. Elimination of flecainide as a function of urinary flow rate and pH. Eur J Clin Pharmacol. 1991;41:61–3.CrossRefPubMed
12.
Zurück zum Zitat Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U, Gleiter CH. Influence of urine pH and urinary flow on the renal excretion of memantine. Br J Clin Pharmacol. 1998;46:541–6.CrossRefPubMedPubMedCentral Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U, Gleiter CH. Influence of urine pH and urinary flow on the renal excretion of memantine. Br J Clin Pharmacol. 1998;46:541–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Presence of an H+/Quinidine Antiport System in Madin–Darby Canine Kidney Cells
verfasst von
Miki Fukao
Eri Kondo
Hiroki Nishino
Ryutaro Hattori
Asuka Horie
Yukiya Hashimoto
Publikationsdatum
01.12.2016
Verlag
Springer International Publishing
Erschienen in
European Journal of Drug Metabolism and Pharmacokinetics / Ausgabe 6/2016
Print ISSN: 0378-7966
Elektronische ISSN: 2107-0180
DOI
https://doi.org/10.1007/s13318-015-0314-1

Weitere Artikel der Ausgabe 6/2016

European Journal of Drug Metabolism and Pharmacokinetics 6/2016 Zur Ausgabe